US 9206161
Bridged bicyclic heteroaryl substituted triazoles useful as Axl inhibitors
granted A61KA61K31/502A61P
Quick answer
US patent 9206161 (Bridged bicyclic heteroaryl substituted triazoles useful as Axl inhibitors) held by Rigel Pharmaceuticals, Inc. expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K31/502, A61P, A61P13/12, A61P15/00